Variant report
Variant | nsv590432 |
---|---|
Chromosome Location | chr3:61416169-61425165 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553988621 | chr3:61416194-61416195 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73837547 | chr3:61416198-61416199 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs547051627 | chr3:61416223-61416224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184289615 | chr3:61416266-61416267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73837548 | chr3:61416340-61416341 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs370228252 | chr3:61416349-61416350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576504602 | chr3:61416360-61416361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6780914 | chr3:61416381-61416382 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs562732384 | chr3:61416398-61416399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575112255 | chr3:61423843-61423844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557856081 | chr3:61423853-61423854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576084054 | chr3:61423869-61423870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187372047 | chr3:61423878-61423879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555116920 | chr3:61423879-61423880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190740230 | chr3:61423887-61423888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs115293931 | chr3:61423896-61423897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182899498 | chr3:61423906-61423907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541756149 | chr3:61423908-61423909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138775625 | chr3:61423958-61423959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201715981 | chr3:61423979-61423980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs578231094 | chr3:61424011-61424012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141343936 | chr3:61424102-61424103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560979710 | chr3:61424141-61424142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529544336 | chr3:61424149-61424150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545648291 | chr3:61424153-61424154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185759294 | chr3:61424277-61424278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530945000 | chr3:61424299-61424300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190167274 | chr3:61424319-61424320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541772579 | chr3:61424346-61424347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561126650 | chr3:61424355-61424356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113836841 | chr3:61424399-61424400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147000757 | chr3:61424404-61424405 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533580793 | chr3:61424418-61424419 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs80327213 | chr3:61424439-61424440 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551857231 | chr3:61424449-61424450 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78813351 | chr3:61424468-61424469 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs397989839 | chr3:61424470-61424471 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141803171 | chr3:61424497-61424498 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551328863 | chr3:61424543-61424544 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531078534 | chr3:61424554-61424555 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569830702 | chr3:61424597-61424598 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536752225 | chr3:61424613-61424614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555401683 | chr3:61424646-61424647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs56752710 | chr3:61424686-61424687 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs534574778 | chr3:61424704-61424705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552985308 | chr3:61424769-61424770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183225722 | chr3:61424775-61424776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187701563 | chr3:61424777-61424778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192712790 | chr3:61424784-61424785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557315523 | chr3:61424813-61424814 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Mental retardation | 17847001 | CNVD |
Neuroticism | 17667963 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 22102821 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:61411200-61416400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr3:61416000-61416200 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr3:61423800-61425400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
4 | chr3:61424000-61424400 | Enhancers | Liver | Liver |
5 | chr3:61424000-61425200 | Enhancers | Fetal Intestine Small | intestine |
6 | chr3:61424000-61425400 | Enhancers | Fetal Lung | lung |
7 | chr3:61424000-61425400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
8 | chr3:61424400-61424600 | Flanking Active TSS | Liver | Liver |
9 | chr3:61424400-61424800 | Enhancers | Fetal Heart | heart |
10 | chr3:61424600-61424800 | Enhancers | Liver | Liver |
11 | chr3:61424600-61425000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
12 | chr3:61424800-61425000 | Flanking Active TSS | Liver | Liver |
13 | chr3:61424800-61425400 | Enhancers | Psoas Muscle | Psoas |
14 | chr3:61425000-61425400 | Enhancers | Liver | Liver |